{"name":"Prestige Consumer Healthcare","slug":"prestige-consumer","ticker":"PBH","exchange":"NYSE","domain":"prestigeconsumerhealthcare.com","description":"Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.","hq":"Tarrytown, NY, USA","founded":1990,"employees":"600","ceo":"Ron Lombardi","sector":"Consumer Healthcare / OTC","stockPrice":55.66,"stockChange":0.04,"stockChangePercent":0.07,"marketCap":"$2.7B","metrics":{"revenue":975777000,"revenueGrowth":-2.4,"grossMargin":57,"rdSpend":0,"netIncome":214605000,"cash":62373000,"dividendYield":0,"peRatio":14.7,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"BC Powder patent cliff ($100.0M at risk)","drug":"BC Powder","type":"patent_expiry","sentiment":"negative"},{"date":"2027-06-01","label":"Chloraseptic patent cliff ($50.0M at risk)","drug":"Chloraseptic","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Prestige Consumer Healthcare Reports Fourth Quarter and Full Year 2023 Results","summary":"Prestige Consumer Healthcare reported fourth quarter and full year 2023 results, with net sales of $234.4 million and $1.0 billion, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-05-18","type":"deal","headline":"Prestige Consumer Healthcare Announces Agreement to Acquire Halls and Luden's from Reckitt Benckiser","summary":"Prestige Consumer Healthcare announced an agreement to acquire the Halls and Luden's brands from Reckitt Benckiser for $700 million.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-06","type":"regulatory","source":"simplywall.st","summary":"Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio - simplywall.st","headline":"Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio","sentiment":"neutral"},{"date":"2026-03-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"pipeline","source":"simplywall.st","summary":"How Prestige’s Media Agency Shift At Prestige Consumer Healthcare (PBH) Has Changed Its Investment Story - simplywall.st","headline":"How Prestige’s Media Agency Shift At Prestige Consumer Healthcare (PBH) Has Changed Its Investment Story","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-02","type":"pipeline","source":"simplywall.st","summary":"Assessing Prestige Consumer Healthcare (PBH) Valuation After Mixed Returns And An 11% Intrinsic Value Discount - simplywall.st","headline":"Assessing Prestige Consumer Healthcare (PBH) Valuation After Mixed Returns And An 11% Intrinsic Value Discount","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQeWs1Ty1wLXBoaEMxelpBcmtVT2psRFUzTUJCdkg2Z0o4UWdwQ18wQlg0blhFY2daalJsWGRocG11RFBIN2VtQkhlbFAyUEZSN2RBTzdqMzVDSUd0RjJXZWh5RFdIS2JOY2lPXzV4anlmNEFucmpCZ2ZJYlRWN0xaNlY4ZTl3S1A3REtPeUJmU2NqZw?oc=5","date":"2026-02-07","type":"pipeline","source":"Yahoo Finance","summary":"Prestige Consumer Healthcare (PBH) Valuation Check After Clear Eyes Supply Headwinds And Pillar5 Acquisition - Yahoo Finance","headline":"Prestige Consumer Healthcare (PBH) Valuation Check After Clear Eyes Supply Headwinds And Pillar5 Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOY3hMYWZsc3hqYXJkclJBdFRnQXJQOFV3NnhHMThUeXVkb1lfMFd2a0VUNDE1VDJucUI1NnI0dTZKSU5FcS1zOWY1MkR2VmR5OG10SVJLejIzYWs4SkVoanlyZkxiV2s0aWJkVURoSlBVSVFPWmc1ZXJINzFQbGtUU0l1ZC1mQ1IyTWRXcFNNdkNZM2kwajBoRGQ1NUJLVlZWRG1lVGFMci1aTkltTklr?oc=5","date":"2026-02-05","type":"pipeline","source":"TradingView","summary":"Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView","headline":"Prestige Consumer Healthcare Inc. SEC 10-Q Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPQmZkRUJ3T2g0UkpHVjBXUGNFVW9CMy1wV0VXQkY0cVJTSllaMkVTWTlCdjhXengzTmRtRldfa05XT2xXMDZMN0ZZUkh1aHM1QlFtX2lkSnlsbDlCSC1IanpjZTlNY1pfdkUycDRPOHY5NjIyRnlhb0JoeEtMYmlfRmxwVmpWZWhCT2xhTi1ObmY5cUZqdGEyeFl5V2pkdGE3YUNzcU13S2hfaTVsdVhIMkdDZURSVXFmWUVqSDRJVDFqU3ZMMzk2LWRIX3ZtV3VGQ1YtSXJoMmg5eldFVVQzNno3R0pTYTFpbjh1NTl5Z2FqMjNhelE?oc=5","date":"2026-02-05","type":"earnings","source":"GlobeNewswire","summary":"Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results - GlobeNewswire","headline":"Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results","sentiment":"neutral"},{"date":"2026-02-05","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-02-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-09","type":"pipeline","source":"simplywall.st","summary":"We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt - simplywall.st","headline":"We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt","sentiment":"neutral"},{"date":"2025-11-06","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOc1ZCaXdKcjY2N00yM1B5OHpfc3FpdkpIb1lXbU5DRV9zbG9Ga1QyZW9WZHZCMW42T0EyeUFXYklMYW01alZvZHlaUjlFRGhJbDc1MmFRaFdyR2R4ZEN5M2VhUDAzaDNxMUV0a3ByR0oxeHZyM0x5Mi1jRy1GOVB0N3JKcFhhM0I1aExhWTJBSm03SDZmTnByZHlxbEpORTRhendyYlJDbGhmTGFyUXJFSmNiNnkzcC1PVGZ3YUlUbVJHWU5YcHVGck5ZS2V4NzRYYU1IZ2VxenpRMlBoLWI5M0tEZHg4bVZPZUVFaEJzMFZ5dWNyQ2JrNVZqeUY?oc=5","date":"2025-09-22","type":"pipeline","source":"Sahm","summary":"A Look at Prestige Consumer Healthcare’s Valuation After the Pillar5 Pharma Acquisition and Rising Market Uncertainty - Sahm","headline":"A Look at Prestige Consumer Healthcare’s Valuation After the Pillar5 Pharma Acquisition and Rising Market Uncertainty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPUFBIOTE2X210YmY1eHg1Rkt5V2lKZ2dmWDU0WXBOZEVsQ0JLak8wNU1jMFZYTmE4N3AtV2k2NklyMEVnMDlLZ0pUVWJXY3plTUxWMkFvcGZHRzBMSklOUjZRZGRVdUJfS3BzNUswcVhvRGtRNG5mWXlFZHlQQjhZMzQ2NzZEeU1sdXc?oc=5","date":"2025-09-18","type":"pipeline","source":"Yahoo Finance","summary":"Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds - Yahoo Finance","headline":"Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOOFYxdl9oeGI5TXU0eFIxalZpMW1xeWRyb2loWXBvTm5NRXpUYzIxYXBHMVFXekdBeVkyLUtaTWVVWWsxcFBwazNBdTQwcEhtczZEaUdzV2hsd3N4VksyV3FOYUhtYlVLWDFSTjFXajVMRGZLdkhtQ0RqLXhIT0x1X004c0RzcVNLTUVHdVZ4amYxdm5TSzdBS3NsTTNYam1lNUtod2pmWVJac0hQcmowX051SkVGS0szQ2JhVWRIam1yQ2RBMExkZW9iSkFPRGxodzcyYWNValdKLXh0LW04?oc=5","date":"2025-08-07","type":"earnings","source":"GlobeNewswire","summary":"Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results - GlobeNewswire","headline":"Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results","sentiment":"neutral"}],"patents":[{"drugName":"BC Powder","drugSlug":"acetaminophen,-aspirin,-and-caffeine","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Chloraseptic","drugSlug":"benzocaine","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":50000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Reckitt Benckiser","Church & Dwight","Henkel"],"therapeuticFocus":["Pain Relief","Cough and Cold"],"financials":{"source":"sec_edgar","revenue":975777000,"revenuePeriod":"2019-03-31","revenueHistory":[{"value":975777000,"period":"2019-03-31"},{"value":713457000,"period":"2015-03-31"},{"value":595639000,"period":"2014-03-31"},{"value":616915000,"period":"2013-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":214605000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":3402218000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":55.66,"previousClose":55.62,"fiftyTwoWeekHigh":89.37,"fiftyTwoWeekLow":51.24,"fiftyTwoWeekRange":"51.24 - 89.37","fiftyDayAverage":64.41,"twoHundredDayAverage":65.78,"beta":0.47,"enterpriseValue":3648784640,"forwardPE":11.6,"priceToBook":1.44,"priceToSales":2.43,"enterpriseToRevenue":3.31,"enterpriseToEbitda":10,"pegRatio":1.78,"ebitda":364984000,"ebitdaMargin":33.1,"freeCashflow":207171120,"operatingCashflow":276633984,"totalDebt":1079289984,"debtToEquity":59,"currentRatio":3.11,"returnOnAssets":6.1,"returnOnEquity":10.3,"analystRating":"","recommendationKey":"none","numberOfAnalysts":6,"targetMeanPrice":78.5,"targetHighPrice":86,"targetLowPrice":66,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":1388102400,"insiderHeldPercent":1.3,"institutionHeldPercent":111.4,"sharesOutstanding":47318730,"floatShares":46749012,"sharesShort":2500238,"shortRatio":5.99,"shortPercentOfFloat":5.3,"epsTrailing":3.79,"epsForward":4.81,"revenuePerShare":22.52,"bookValue":38.66,"officers":[{"age":49,"name":"Ms. Christine  Sacco CPA","title":"CFO & COO"},{"age":60,"name":"Mr. William C. P'Pool J.D.","title":"Senior VP, General Counsel & Corporate Secretary"},{"age":63,"name":"Mr. Adel  Mekhail","title":"Executive Vice President of Marketing & Sales"},{"age":63,"name":"Mr. Jeffrey  Zerillo","title":"Senior Vice President of Operations"},{"age":null,"name":"Mr. Philip David Terpolilli C.F.A.","title":"Director of Investor Relations"},{"age":null,"name":"Dean  Siegal","title":"Director of Communications"},{"age":null,"name":"Mr. Jose Luis Rosado","title":"Senior Vice President of Quality & Regulatory Affairs"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"http://ir.prestigebrands.com/phoenix.zhtml?c=182173&p=irol-irHome","website":"https://www.prestigebrands.com","phone":"914 524 6800"}}